Medicover AB (publ) (STO:MCOV.B)
Sweden · Delayed Price · Currency is SEK 215.00
+5.00 (2.38%)
At close: Jun 17, 2026
Medicover AB Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Medicover AB stock has a consensus rating of "Buy" and an average price target of kr 259.87. The average 1-year stock price forecast is 20.87% higher than the current stock price, while the lowest is kr 222.76 (+3.61%) and the highest is kr 302.07 (+40.50%).
Price Target: kr 259.87 (+20.87%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Medicover AB stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
2.66B
from 2.38B
Increased by 12.00%
Revenue Next Year
2.99B
from 2.66B
Increased by 12.11%
EPS This Year
0.71
from 0.64
Increased by 10.64%
EPS Next Year
0.96
from 0.71
Increased by 35.15%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.8B | ||
| Avg | 2.7B | ||
| Low | 2.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.7% | ||
| Avg | 12.0% | ||
| Low | 9.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.71 | ||
| Avg | 0.71 | ||
| Low | 0.70 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.2% | ||
| Avg | 10.6% | ||
| Low | 9.6% |